Form 4 for CYRX Cryoport, Inc.
Accepted 2022-03-16 00:00:00 ET · period of report 2022-03-14 · accession 0001104659-22-034628 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-16 | 2022-03-14 | CYRX | SHELTON JERRELL | CEO, Dir | A - Grant | $0.00 | +27.1K | 431.1K | +7% | $0 |
| D | 2022-03-16 | 2022-03-14 | CYRX | SHELTON JERRELL | CEO, Dir | A - Grant | $0.00 | +61.0K | 61.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-14 | A | A | 27,092 | $0.00 | 431,136 | D | — | — | (F1) Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023. |
| 2 | Derivative | Stock Option (right to buy) | 2022-03-14 | A | A | 60,952 | $0.00 | 60,952 | D | $29.69 · — to 2029-03-14 | 60,952 Common Stock | (F2) 1/48 of options vest on the 14th of each month for forty-eight months beginning 4/14/2022. |